AiCure, a NYC-based AI and advanced data analytics company focused on clinical trials, raised $12M loan refinancing and has also raised an additional $4M+ from its existing investors.
The company intends to use the funds to invest in research and development, expand operations, and enhance AiCure products and services.
AiCure is an AI and advanced data analytics company dedicated to enhancing clinical trials with funding, patents, expanded base, and innovative tech. Its software and technology are designed to improve patient engagement and sponsor insights in clinical trials, making it a valuable player in the life sciences industry.
AiCure has received seven new US patents in 2023, which enhance its inventive digital biomarker solutions as well as continue to support its core businesses. These additional patents bring its total patent count in the US to 86, with additional patents issued around the globe.
The company has added two new members, Sondra Pepe and Josh Wilson, to its Senior Leadership Team.
- Sondra Pepe has joined AiCure as the Senior Vice President of Product Management. With nearly 20 years of experience in eClinical SaaS technology, including leading roles in product management at prominent companies such as Medidata, Veeva, Medrio, and ArisGlobal, she brings a wealth of expertise to her new role. Pepe is responsible for leading the product management and testing teams at AiCure, overseeing the product direction, definition, and delivery of the company’s artificial intelligence platform.
- Josh Wilson has joined AiCure as Senior Vice President of Operations. Mr. Wilson brings with him a wealth of experience, having spent nearly two decades at Syneos Health and INC Research, where he was responsible for building and managing data management and technology implementation teams, as well as driving innovative strategies and strategic vendor engagements. Mr. Wilson oversees the operations teams responsible for delivery of the company’s platform and site services.
FinSMEs
25/01/2024